ADAPTABLE trial. Aspirin doses for secondary prevention. NEJM 2021
Cardio-Ed
English - July 24, 2021 00:30 - 4 minutes - 2.86 MB - ★★★★★ - 1 ratingMedicine Health & Fitness cardiology interventional cardiology echocardiography clinical trials medicine structural heart disease heart failure arrhythmia myocardial infarction cardiomyopathy Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: REHAB - HF trial & rehabilitation in older heart failure patients
#ADAPTABLE trial was recently published in NEJM 2021 and it was also presented at ACC 2021 conference. It compared #HighDoseAspirin and #LowDoseAspirin in patients receiving it for secondary prevention.
Follow Cardio-Ed for more such content. We discuss Recent advances, recent guidelines and recent articles in cardiology as well as core concepts in Cardiology.
https://youtube.com/channel/UCVxInTblTpoy-THMuSxNyvw